JUDITH CURRIE: Open Payments
NPI 1134784481 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$697 in 30 payments from 15 companies in 2025. Trend: 2023 $1,686 · 2024 $1,469 · 2025 $697
Food & beverage: $697
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $145 |
| Lilly USA, LLC | 6 | $144 |
| Gilead Sciences, Inc. | 2 | $69 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 1 | $43 |
| Janssen Pharmaceuticals, Inc | 2 | $43 |
| Medtronic, Inc. | 1 | $37 |
| Exact Sciences Corporation | 2 | $34 |
| Inspire Medical Systems, Inc. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $22 |
Products named: MOUNJARO, Ozempic, REXULTI, BREZTRI, SPRAVATO, INTERSTIM, Wegovy, Rybelsus.
Industry payments across GA — which companies pay providers there.
